CoChat

In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations

Open access
Rathmell, W. Kimryn, Hickey, Michele M., Bezman, Natalie A., Chmielecki, Christie A., Carraway, Natalie C., Simon, M. Celeste · 2004 · Cancer Research
Cited by 64

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Mutations in the von Hippel-Lindau (VHL) tumor suppressor gene cause tissue-specific tumors, with a striking genotype-phenotype correlation. Loss of VHL expression predisposes to hemangioblastoma and clear cell renal cell carcinoma, whereas specific point mutations predispose to pheochromocytoma, polycythemia, or combinations of hemangioblastoma, renal cell carcinoma, and/or pheochromocytoma. The VHL protein (pVHL) has been implicated in many cellular activities including the hypoxia response, cell cycle arrest, apoptosis, and extracellular matrix remodeling. We have expressed missense pVHL mutations in Vhl−/− murine embryonic stem cells to test genotype-phenotype correlations in euploid cells. We first examined the ability of mutant pVHL to direct degradation of the hypoxia inducible factor (HIF) subunits HIF1α and HIF2α. All mutant pVHL proteins restored proper hypoxic regulation of HIF1α, although one VHL mutation (VHLR167Q) displayed impaired binding to Elongin C. This mutation also failed to restore HIF2α regulation. In separate assays, these embryonic stem cells were used to generate teratomas in immunocompromised mice, allowing independent assessment of the effects of specific VHL mutations on tumor growth. Surprisingly, teratomas expressing the VHLY112H mutant protein displayed a growth disadvantage, despite restoring HIFα regulation. Finally, we observed increased microvessel density in teratomas derived from Vhl−/− as well as VHLY112H, VHLR167Q, and VHLR200W embryonic stem cells. Together, these observations support the hypothesis that pVHL plays multiple roles in the cell, and that these activities can be separated via discrete VHL point mutations. The ability to dissect specific VHL functions with missense mutations in a euploid model offers a novel opportunity to elucidate the activities of VHL as a tumor suppressor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-04-1430

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 64

Metadata

Authors
Rathmell, W. K., Hickey, M. M., Bezman, N. A., Chmielecki, C. A., Carraway, N. C., & Simon, M. C.
Venue
Cancer Research
Published
2004-12-01
Volume
64
Issue
23
Pages
8595-8603
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2169923647
Cited by
64
References
13
FWCI
1.84
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations. https://app.cochat.ai/papers/10.1158/0008-5472.can-04-1430
The paper
Rathmell, W. K., Hickey, M. M., Bezman, N. A., Chmielecki, C. A., Carraway, N. C., & Simon, M. C. (2004). In vitro and In vivo Models Analyzing von Hippel-Lindau Disease-Specific Mutations. Cancer Research. https://doi.org/10.1158/0008-5472.can-04-1430

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.